Since obtaining approval from the US Food and Drug Administration (FDA) in 2006, Sunitinib has been widely used in clinical practice.
Sunitinib can inhibit the proliferation and spread of tumor cells by suppressing the activity of tyrosine kinase receptors such as KIT, PDGFR α, and VEGFR, thereby exerting anti-tumor effects.
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: